1100 13th Street, NW, Suite 1000Washington, DC 20005202.887.6400Toll-free: 800.544.0155
All Contents © 2020The Kiplinger Washington Editors
Matrix Advisors Value's decision to load up on undervalued giants is finally paying off.
A good first quarter and a rush of deal-making has revived the sector. For smart investors with a stomach for risk, there could be some finds.
Favorable comments about this early-generation biotechnology stock helped send its price up more than 4% yesterday. But can it ever be more than a trading vehicle?
More Investing News »